Related Experiment Video
Updated: May 26, 2025
Author Spotlight: Investigating Wound Healing in Mice Models of Oronasal Fistulas
Published on: September 8, 2023
Effects of Myroxylon pereirae, Phenytoin, and Clinoptilolite After Pharyngocutaneous Fistula: An Experimental Animal
Erim Pamuk1, Enes Dogan1, Olcay Kurtulan2
1Department of Otorhinolaryngology, Hacettepe University, Ankara, Turkey.
Objective:
The objective of this study was to conduct a comparative evaluation of the effects of Myroxylon pereirae (MP), phenytoin, and clinoptilolite on wound healing in an experimental animal model for the treatment of pharyngocutaneous fistula (PCF).
Study Design:
Prospective controlled animal study.
Setting:
Animal laboratory.
Methods:
Forty-four male Sprague-Dawley rats were randomly assigned to one of four groups: sham control group, MP group, phenytoin group, and clinoptilolite group. A PCF was created in each rat via surgical intervention, followed by a course of topical treatment administered twice daily for a period of 7 days. The healing of the fistula was evaluated both macroscopically and histopathologically.
Results:
Macroscopic fistulae developed in 90% of the control group, 18% of the MP group, and 27% of the phenytoin group (P = .005). The phenytoin group had the lowest inflammation scores, which were significantly lower than the clinoptilolite and control groups (P = .006 and P = .001). The MP group had the highest levels of fibroblast proliferation and collagen accumulation (P < .001 and P = .001, respectively). The level of inflammation and amount of fibroblast proliferation, angiogenesis, and collagen accumulation in the clinoptilolite group was lower than in the control group, but none of these differences were significant statistically.
Conclusion:
MP and phenytoin improved the healing of PCF, particularly by reducing the inflammation and promoting the of fibroblast proliferation and collagen accumulation. Clinoptilolite did not demonstrate a notable advantage in any of these parameters. These findings suggest that MP and phenytoin may serve as potential agents in the management of PCF.
